Cargando…
The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926899/ https://www.ncbi.nlm.nih.gov/pubmed/35297182 http://dx.doi.org/10.1002/ctm2.748 |
| _version_ | 1784670334618697728 |
|---|---|
| author | Reisqs, Jean‐Baptiste Moreau, Adrien Charrabi, Azzouz Sleiman, Yvonne Meli, Albano C. Millat, Gilles Briand, Veronique Beauverger, Philippe Richard, Sylvain Chevalier, Philippe |
| author_facet | Reisqs, Jean‐Baptiste Moreau, Adrien Charrabi, Azzouz Sleiman, Yvonne Meli, Albano C. Millat, Gilles Briand, Veronique Beauverger, Philippe Richard, Sylvain Chevalier, Philippe |
| author_sort | Reisqs, Jean‐Baptiste |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8926899 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89268992022-03-24 The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy Reisqs, Jean‐Baptiste Moreau, Adrien Charrabi, Azzouz Sleiman, Yvonne Meli, Albano C. Millat, Gilles Briand, Veronique Beauverger, Philippe Richard, Sylvain Chevalier, Philippe Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-03-16 /pmc/articles/PMC8926899/ /pubmed/35297182 http://dx.doi.org/10.1002/ctm2.748 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Reisqs, Jean‐Baptiste Moreau, Adrien Charrabi, Azzouz Sleiman, Yvonne Meli, Albano C. Millat, Gilles Briand, Veronique Beauverger, Philippe Richard, Sylvain Chevalier, Philippe The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy |
| title | The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy |
| title_full | The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy |
| title_fullStr | The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy |
| title_full_unstemmed | The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy |
| title_short | The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy |
| title_sort | pparγ pathway determines electrophysiological remodelling and arrhythmia risks in dsc2 arrhythmogenic cardiomyopathy |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926899/ https://www.ncbi.nlm.nih.gov/pubmed/35297182 http://dx.doi.org/10.1002/ctm2.748 |
| work_keys_str_mv | AT reisqsjeanbaptiste theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT moreauadrien theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT charrabiazzouz theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT sleimanyvonne theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT melialbanoc theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT millatgilles theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT briandveronique theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT beauvergerphilippe theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT richardsylvain theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT chevalierphilippe theppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT reisqsjeanbaptiste ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT moreauadrien ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT charrabiazzouz ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT sleimanyvonne ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT melialbanoc ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT millatgilles ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT briandveronique ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT beauvergerphilippe ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT richardsylvain ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy AT chevalierphilippe ppargpathwaydetermineselectrophysiologicalremodellingandarrhythmiarisksindsc2arrhythmogeniccardiomyopathy |